# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001731122-24-000760
Filing Date
2024-05-09
Accepted
2024-05-09 16:35:55
Documents
48
Period of Report
2024-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-Q | e5644_10q.htm iXBRL | 10-Q | 684679
2 | EXHIBIT 31.1 | e5644_ex31-1.htm | EX-31.1 | 7969
3 | EXHIBIT 31.2 | e5644_ex31-2.htm | EX-31.2 | 7932
4 | EXHIBIT 32.1 | e5644_ex32-1.htm | EX-32.1 | 5772
5 | GRAPHIC | image_001.jpg | GRAPHIC | 27704
6 | GRAPHIC | image_002.jpg | GRAPHIC | 28815
| Complete submission text file | 0001731122-24-000760.txt |  | 3485019

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL SCHEMA FILE | avxl-20240331.xsd | EX-101.SCH | 26713
8 | XBRL CALCULATION FILE | avxl-20240331_cal.xml | EX-101.CAL | 27975
9 | XBRL DEFINITION FILE | avxl-20240331_def.xml | EX-101.DEF | 89589
10 | XBRL LABEL FILE | avxl-20240331_lab.xml | EX-101.LAB | 247467
11 | XBRL PRESENTATION FILE | avxl-20240331_pre.xml | EX-101.PRE | 193967
51 | EXTRACTED XBRL INSTANCE DOCUMENT | e5644_10q_htm.xml | XML | 443504

Mailing Address 630 5TH AVENUE 20TH FLOOR NEW YORK NY 10111
Business Address 630 5TH AVENUE 20TH FLOOR NEW YORK NY 10111 844-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

EIN.: 980608404 | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-37606 | Film No.: 24931371
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)